Yaacov-Garbeli Dana 4
4 · Entera Bio Ltd. · Filed Nov 15, 2022
Insider Transaction Report
Form 4
Entera Bio Ltd.ENTX
Yaacov-Garbeli Dana
Chief Financial Officer
Transactions
- Purchase
Ordinary Shares, par value NIS 0.0000769 per share
2022-11-14$0.54/sh+26,580$14,247→ 56,580 total(indirect: By A2Z Counseling Ltd.) - Purchase
Ordinary Shares, par value NIS 0.0000769 per share
2022-11-11$0.52/sh+30,000$15,600→ 30,000 total(indirect: By A2Z Counseling Ltd.)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.50 to $0.54, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]These shares are owned by A2Z Counseling Ltd. of which the Reporting Person's owns a 33.33% interest and has effective control over voting and disposition of the shares. The Reporting Person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.53 to $0.54, inclusive. The reporting person undertakes to provide to Entera Bio Ltd., an Israeli company ("Entera Bio"), any security holder of Entera Bio, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.